Mechanical Alteration Associated With Chemotherapeutic Resistance of Breast Cancer Cells

Park, Soyeun

Abstract

BACKGROUND
The mechanical deformability of cancer cells has attracted particular attention as an emerging biomarker for the prediction of anti-cancer drug sensitivity. Nevertheless, it has not been possible to establish a general rubric for the identification of drug susceptibility in breast cancer cells from a mechanical perspective. In the present study, we investigated the mechanical alteration associated with resistance to adjuvant therapy in breast cancer cells.
METHODS
We performed an "˜atomic force microscopy (AFM)-based nanomechanical study' on "˜drug-sensitive (MCF-7)' and "˜drug-resistant (MCF-7/ADR)' breast cancer cells. We also conducted cell viability tests to evaluate the difference in doxorubicin responsiveness between two breast cancer cell lines. We carried out a wound closure experiment to investigate the motility changes associated with chemotherapeutic resistance. To elucidate the changes in molecular alteration that accompany chemotherapeutic resistance, we investigated the expression of vinculin and integrin-linked kinase-1-which are proteins involved in substrate adhesion and the actin cytoskeleton-using Western blotting analysis.
RESULTS
A MTT assay confirmed that the dose-dependent efficacy of doxorubicin was reduced in MCF-7/ADR cells compared to that in MCF-7 cells. The wound assay revealed enhanced two-dimensional motility in the MCF-7/ADR cells. The AFM mechanical assay showed evidence that the drug-resistant breast cancer cells exhibited a significant decrease in mechanical deformability compared to their drug-sensitive counterparts. The mechanical alteration in the MCF-7/ADR cells was accompanied by upregulated vinculin expression.
CONCLUSIONS
The obtained results manifestly showed that the altered mechanical signatures-including mechanical deformability and motility-were closely related with drug resistance in the breast cancer cells. We believe that this investigation has improved our understanding of the chemotherapeutic susceptibility of breast cancer cells.